• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov6
Tempest Therapeutics released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.7907 (forecast USD -3.27)
04:00
Tempest Therapeutics released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 0 and EPS of USD -6.0193
04:00
Aug12
Tempest Therapeutics released FY2025 Semi-Annual earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -5.1721 (forecast USD -9.62)
03:00
Tempest Therapeutics released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.07 (forecast USD -3.23)
03:00
Jun30
Tempest Therapeutics Gains NMPA Approval for Liver Cancer Drug Trial
12:00
Jun12
Tempest Therapeutics Inc. Files $6.25M Direct Offering Prospectus
20:19

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.511 M, EPS -0.7907

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.87 M, EPS -2.0694

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.86 M, EPS -3.1591

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy